Immunogenetics of Sjogren's syndrome

被引:0
作者
Kassan, SS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
来源
ANNALES DE MEDECINE INTERNE | 1998年 / 149卷 / 01期
关键词
Sjogren's syndrome; HLA antigens; HLA-DQ alleles; HLA-DR3; Anti-Ro; Anti-La;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The etiology for SS remains unknown where multifactorial influences contribute to the pathogenesis of subsequent development of the disease. The genetic influence Is also multifactorial and the data suggests a familial component indicative of autosomal-dominant genes as well as genetic contributions associated with class-I and class-II HLA alleles. Various auto-antibodies found with increased frequency in SS (anti-Re and anti-La) were shown to be associated with HLA class-II alleles at the DQA(1) and DQB(1) loci that mere also found to have in common specific amino acid residues (10). Ethnic groups have also been studied and show varying HLA associations with primary SS. Multiple ethnic groups, however, share a DQ allele supporting the idea that the majority of SS patients carry a common allele which may predispose to primary SS. In some cases, the HLA-DR antigen may be induced and cause to appear on epithelial cells where they present antigen to Co 4+ T-cells, which then go on to aid in the destruction of salivary gland epithelial cells specifically. The further elucidation of disease associations as well as possible immunogenetic pathogenic mechanisms may help to explain the causes for the development of various autoimmune diseases such as Sjogren's Syndrome. This may eventually result in the ability to immunomodulate these abnormal immune responses. In so doing, an approach to treatment by genetic engineering may also be possible once a further understanding of the genetic influences and mechanisms in the causation of autoimmune disease is further elucidated.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 50 条
  • [1] Is There a Need for Such a Naming: Seronegative Primary Sjogren's Syndrome?
    Karahan, Samet
    Karabulut, Aycan
    TURKISH JOURNAL OF IMMUNOLOGY, 2021, 9 (03): : 128 - 133
  • [2] Sjogren's syndrome
    Amarasena, Roshan
    Bowman, Simon
    CLINICAL MEDICINE, 2007, 7 (01) : 53 - 56
  • [3] Sjogren's syndrome
    Venables, PJW
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (03): : 313 - 329
  • [4] Sjogren's Syndrome
    Troester, Isabella
    Juelich, Maike
    Voll, Reinhard Edmund
    Kollert, Florian
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (04) : 291 - 300
  • [5] Sjogren's Syndrome
    Corominas, Hector
    Figuls, Ramon
    Riera, Manel
    REUMATOLOGIA CLINICA, 2008, 4 : 22 - 27
  • [6] Sjogren's Syndrome
    Mavragani, Clio P.
    Moutsopoulos, Haralampos M.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9, 2014, 9 : 273 - 285
  • [7] Clinical and serological characteristics of seronegative primary Sjogren's syndrome: a comparative study
    Yazisiz, Veli
    Aslan, Bengisu
    Erbasan, Funda
    Ucar, Ismail
    Ogut, Tahir Saygin
    Terzioglu, Ender
    CLINICAL RHEUMATOLOGY, 2021, 40 (01) : 221 - 229
  • [8] Sjogren's syndrome: Terminology
    Oxholm, P
    Asmussen, K
    Axell, T
    VanBijsterveld, OP
    Jacobsson, L
    Konttinen, Y
    Manthorpe, R
    Nederfors, T
    Prause, JU
    Schiodt, M
    Thorn, JJ
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1995, 13 (06) : 693 - 696
  • [9] Pathophysiology of Sjogren's syndrome
    Garcia-Carrasco, Mario
    Fuentes-Alexandro, Salvador
    Escarcega, Ricardo O.
    Salgado, Gonzalo
    Riebeling, Carlos
    Cervera, Ricard
    ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (08) : 921 - 932
  • [10] The management of Sjogren's syndrome
    Mavragani, CP
    Moutsopoulos, NM
    Moutsopoulos, HM
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (05): : 252 - 261